agilon health, inc. Depreciation
agilon health, inc. (AGL) reported Depreciation of $1.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-02-25
- agilon health, inc. depreciation for the quarter ending 2025-12-31 was -$10.00M.
- agilon health, inc. depreciation for the quarter ending 2025-09-30 was $3.80M, a 22.58% increase year-over-year.
- agilon health, inc. depreciation for the quarter ending 2025-06-30 was $3.90M, a 34.48% increase year-over-year.
- agilon health, inc. depreciation for the quarter ending 2025-03-31 was $3.80M, a 35.71% increase year-over-year.
- agilon health, inc. depreciation for fiscal 2025 was $1.50M, a 11.76% decline from fiscal 2024.
- agilon health, inc. depreciation for fiscal 2024 was $1.70M, a 5.56% decline from fiscal 2023.
- agilon health, inc. depreciation for fiscal 2023 was $1.80M, a 53.85% decline from fiscal 2022.
- agilon health, inc. depreciation for fiscal 2022 was $3.90M, a 69.57% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | -$10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$6.20M derived: sum of 2 quarters · filed 2026-02-25 | -$2.30M derived: sum of 3 quarters · filed 2026-02-25 | $1.50M 10-K · filed 2026-02-25 | ||
| 2025-09-30 | $3.80M 10-Q · filed 2025-11-04 | $7.70M derived: sum of 2 quarters · filed 2025-11-04 | $11.50M 10-Q · filed 2025-11-04 | $4.30M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2025-06-30 | $3.90M 10-Q · filed 2025-08-04 | $7.70M 10-Q · filed 2025-08-04 | $500.00K derived: sum of 3 quarters · filed 2026-02-25 | $3.60M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2025-03-31 | $3.80M 10-Q · filed 2025-05-06 | -$3.40M derived: sum of 2 quarters · filed 2026-02-25 | -$300.00K derived: sum of 3 quarters · filed 2026-02-25 | $2.60M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-12-31 | -$7.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$4.10M derived: sum of 2 quarters · filed 2026-02-25 | -$1.20M derived: sum of 3 quarters · filed 2026-02-25 | $1.70M 10-K · filed 2026-02-25 | $12.20M 10-K · filed 2025-02-25 | |
| 2024-09-30 | $3.10M 10-Q · filed 2025-11-04 | $6.00M derived: sum of 2 quarters · filed 2025-11-04 | $8.90M 10-Q · filed 2025-11-04 | $5.00M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-06-30 | $2.90M 10-Q · filed 2025-08-04 | $5.80M 10-Q · filed 2025-08-04 | $1.90M derived: sum of 3 quarters · filed 2026-02-25 | $4.00M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-03-31 | $2.80M 10-Q · filed 2025-05-06 | -$1.00M derived: sum of 2 quarters · filed 2026-02-25 | $1.10M derived: sum of 3 quarters · filed 2026-02-25 | $2.90M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2023-12-31 | -$3.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$1.70M derived: sum of 2 quarters · filed 2026-02-25 | $100.00K derived: sum of 3 quarters · filed 2026-02-25 | $1.80M 10-K · filed 2026-02-25 | $8.00M 10-K · filed 2024-02-27 | |
| 2023-09-30 | $2.10M 10-Q · filed 2024-11-07 | $3.90M derived: sum of 2 quarters · filed 2024-11-07 | $5.60M 10-Q · filed 2024-11-07 | $6.80M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-06-30 | $1.80M 10-Q · filed 2024-08-06 | $3.50M 10-Q · filed 2024-08-06 | $4.70M derived: sum of 3 quarters · filed 2025-02-25 | $6.10M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-03-31 | $1.70M 10-Q · filed 2024-05-07 | $2.90M derived: sum of 2 quarters · filed 2025-02-25 | $4.30M derived: sum of 3 quarters · filed 2025-02-25 | $4.90M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2022-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $2.60M derived: sum of 2 quarters · filed 2025-02-25 | $3.20M derived: sum of 3 quarters · filed 2025-02-25 | $3.90M 10-K · filed 2025-02-25 | $4.00M 10-K · filed 2023-03-01 | |
| 2022-09-30 | $1.40M 10-Q · filed 2023-11-02 | $2.00M derived: sum of 2 quarters · filed 2023-11-02 | $2.70M 10-Q · filed 2023-11-02 | $3.20M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-06-30 | $600.00K 10-Q · filed 2023-08-03 | $1.30M 10-Q · filed 2023-08-03 | $1.80M derived: sum of 3 quarters · filed 2024-02-27 | $2.40M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-03-31 | $700.00K 10-Q · filed 2023-05-09 | $1.20M derived: sum of 2 quarters · filed 2024-02-27 | $1.80M derived: sum of 3 quarters · filed 2024-02-27 | $2.40M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2021-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.10M derived: sum of 2 quarters · filed 2024-02-27 | $1.70M derived: sum of 3 quarters · filed 2024-02-27 | $2.30M 10-K · filed 2024-02-27 | $2.60M 10-K · filed 2022-03-03 | |
| 2021-09-30 | $600.00K 10-Q · filed 2022-11-03 | $1.20M derived: sum of 2 quarters · filed 2022-11-03 | $1.80M 10-Q · filed 2022-11-03 | $2.40M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-06-30 | $600.00K 10-Q · filed 2022-08-04 | $1.10M 10-Q · filed 2022-08-04 | $1.20M 10-Q · filed 2021-08-04 | $1.80M derived: sum of 3 quarters · filed 2023-03-01 | $2.30M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | $600.00K 10-Q · filed 2022-05-05 | $1.20M derived: sum of 2 quarters · filed 2023-03-01 | $1.70M derived: sum of 3 quarters · filed 2023-03-01 | $2.20M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2020-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.10M derived: sum of 2 quarters · filed 2023-03-01 | $1.60M derived: sum of 3 quarters · filed 2023-03-01 | $2.20M 10-K · filed 2023-03-01 | ||
| 2020-09-30 | $500.00K 10-Q · filed 2021-10-28 | $1.00M derived: sum of 2 quarters · filed 2021-10-28 | $1.60M 10-Q · filed 2021-10-28 | |||
| 2020-06-30 | $500.00K 10-Q · filed 2021-08-04 | $1.00M 10-Q · filed 2021-08-04 | ||||
| 2020-03-31 | $500.00K 10-Q · filed 2021-05-26 | |||||
| 2019-12-31 | $1.60M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |